{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:05:03Z","timestamp":1790996703174,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":595,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NEI","award":["5R21EY018708-02"],"award-info":[{"award-number":["5R21EY018708-02"]}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIA","award":["R21AG027445A"],"award-info":[{"award-number":["R21AG027445A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bbadis.2011.08.013","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T10:28:50Z","timestamp":1315650530000},"page":"1584-1590","source":"Crossref","is-referenced-by-count":124,"title":["Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine"],"prefix":"10.1016","volume":"1812","author":[{"given":"Thimmappa S.","family":"Anekonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2011.08.013_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/lm.773208","article-title":"Conditional forebrain deletion of the L-type calcium channel CaV1.2 disrupts remote spatial memories in mice","volume":"15","author":"White","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cne.21567","article-title":"Ultrastructural evidence for pre- and postsynaptic localization of Cav1.2 L-type Ca2+ channels in the rat hippocampus","volume":"506","author":"Tippens","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2007.10.009","article-title":"Cav1.2 calcium channels modulate the spiking pattern of hippocampal pyramidal cells","volume":"82","author":"Lacinova","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuron.2007.06.032","article-title":"AKAP79\/150 anchoring of calcineurin controls neuronal L-type Ca2+ channel activity and nuclear signaling","volume":"55","author":"Oliveria","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0025","doi-asserted-by":"crossref","first-page":"9883","DOI":"10.1523\/JNEUROSCI.1531-05.2005","article-title":"Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory","volume":"25","author":"Moosmang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0030","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0024-3205(97)00881-3","article-title":"Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists","volume":"61","author":"Uchida","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study","volume":"64","author":"Nixon","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0045","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2008.04.015","article-title":"Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating","volume":"58","author":"Cheung","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0050","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease","volume":"3","author":"LaFerla","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0055","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2008.05.048","article-title":"A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk","volume":"133","author":"Dreses-Werringloer","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuron.2008.07.013","article-title":"Linking calcium to Abeta and Alzheimer's disease","volume":"59","author":"Green","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00926750","article-title":"beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease","volume":"140","author":"Arispe","year":"1994","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00001756-199612200-00074","article-title":"Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide","volume":"8","author":"Guo","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0080","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.200706171","article-title":"SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production","volume":"181","author":"Green","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0085","doi-asserted-by":"crossref","first-page":"18195","DOI":"10.1074\/jbc.M000040200","article-title":"Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons","volume":"275","author":"Chan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0090","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1471-4159.2007.05135.x","article-title":"Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice","volume":"105","author":"Lopez","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0095","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1523\/JNEUROSCI.2047-09.2009","article-title":"Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice","volume":"29","author":"Chakroborty","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0100","doi-asserted-by":"crossref","first-page":"12128","DOI":"10.1523\/JNEUROSCI.2474-10.2010","article-title":"NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice","volume":"30","author":"Goussakov","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0105","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1471-4159.2005.03332.x","article-title":"Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease","volume":"94","author":"Smith","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1474-9726.2007.00275.x","article-title":"Calcium and neurodegeneration","volume":"6","author":"Mattson","year":"2007","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1471-4159.1997.68010265.x","article-title":"Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals","volume":"68","author":"Ueda","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0125","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3233\/JAD-2010-091117","article-title":"L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M\/N671L) mutations","volume":"20","author":"Willis","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0130","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.1523\/JNEUROSCI.4164-08.2010","article-title":"Homeostatic switch in hebbian plasticity and fear learning after sustained loss of Cav1.2 calcium channels","volume":"30","author":"Langwieser","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0135","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.21937","article-title":"L-type calcium channel blockers and Parkinson disease in Denmark","volume":"67","author":"Ritz","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0140","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1111\/j.1460-9568.2006.04734.x","article-title":"Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB","volume":"23","author":"Zhang","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2010.08.020","article-title":"L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease","volume":"41","author":"Anekonda","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0150","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1096\/fj.10-156661","article-title":"Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity","volume":"24","author":"Wang","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0155","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/bi062217x","article-title":"Critical role of cAMP-dependent protein kinase anchoring to the L-type calcium channel Cav1.2 via A-kinase anchor protein 150 in neurons","volume":"46","author":"Hall","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0160","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/j.1471-4159.2005.03307.x","article-title":"Phosphorylation of tau at serine 416 by Ca2+\/calmodulin-dependent protein kinase II in neuronal soma in brain","volume":"94","author":"Yamamoto","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0165","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0021-9258(18)54055-2","article-title":"Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly","volume":"268","author":"Scott","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2008-14409","article-title":"Tau aggregation and toxicity in tauopathic neurodegenerative diseases","volume":"14","author":"Honson","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0175","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of Abeta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0180","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1242\/jcs.019265","article-title":"Autophagy, amyloidogenesis and Alzheimer disease","volume":"120","author":"Nixon","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0185","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0190","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.200505082","article-title":"Macroautophagy\u2014a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease","volume":"171","author":"Yu","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0200","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tins.2006.07.003","article-title":"Autophagy in neurodegenerative disease: friend, foe or turncoat?","volume":"29","author":"Nixon","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0205","doi-asserted-by":"crossref","first-page":"21978","DOI":"10.1074\/jbc.M110.110940","article-title":"A caspase cleaved form of tau is preferentially degraded through the autophagy pathway","volume":"285","author":"Dolan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0210","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","article-title":"Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations","volume":"141","author":"Lee","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0215","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jnen\/64.2.104","article-title":"The role of caspase cleavage of tau in Alzheimer disease neuropathology","volume":"64","author":"Cotman","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0220","doi-asserted-by":"crossref","first-page":"e1001026","DOI":"10.1371\/journal.pgen.1001026","article-title":"Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo","volume":"6","author":"Khurana","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0225","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1073\/pnas.87.10.3861","article-title":"Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain","volume":"87","author":"Cataldo","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0230","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1460-9568.2008.06084.x","article-title":"Autophagic\u2013lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression","volume":"27","author":"Hamano","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0235","first-page":"2190","article-title":"The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice","volume":"118","author":"Pickford","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0240","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0245","doi-asserted-by":"crossref","first-page":"e12845","DOI":"10.1371\/journal.pone.0012845","article-title":"Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease","volume":"5","author":"Ma","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0250","doi-asserted-by":"crossref","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0255","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.expneurol.2009.06.008","article-title":"Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease","volume":"223","author":"Cardoso","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(94)90589-4","article-title":"Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat","volume":"171","author":"Braak","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1460-9568.2008.06329.x","article-title":"Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load","volume":"28","author":"Koson","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0270","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00401-009-0491-6","article-title":"Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models","volume":"117","author":"Zhang","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0275","doi-asserted-by":"crossref","first-page":"37920","DOI":"10.1074\/jbc.M110.185728","article-title":"Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease","volume":"285","author":"Siddiqua","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-2010-101434","article-title":"Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's disease cellular model","volume":"23","author":"Zilkova","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0285","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jnen\/64.1.15","article-title":"Calpain inhibitor inhibits p35-p25-Cdk5 activation, decreases tau hyperphosphorylation, and improves neurological function after spinal cord hemisection in rats","volume":"64","author":"Hung","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0295","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1432-1033.1995.009_1.x","article-title":"Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments","volume":"233","author":"Yang","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0300","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jnen\/64.3.209","article-title":"Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry","volume":"64","author":"Fujino","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0305","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1074\/jbc.M808908200","article-title":"Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease","volume":"284","author":"Quintanilla","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0310","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.febslet.2006.05.029","article-title":"Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo","volume":"580","author":"Zilka","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0315","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature08890","article-title":"Caspase activation precedes and leads to tangles","volume":"464","author":"de Calignon","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0320","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","article-title":"Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines","volume":"30","author":"Zempel","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0325","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0330","first-page":"439","article-title":"Clinical findings with nimodipine in dementia: test of the calcium hypothesis","volume":"46","author":"Fritze","year":"1995","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0335","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0006-3223(90)90050-C","article-title":"Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia","volume":"27","author":"Tollefson","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0340","series-title":"Cochrane Database of Systematic Reviews","article-title":"Nimodipine for primary degenerative, mixed and vascular dementia","author":"Lopez-Arrieta","year":"2002"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0345","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00044011-199611040-00001","article-title":"Nimodipine in the treatment of probably Alzheimer's disease results of two multicentre trials","volume":"11","author":"Morich","year":"1996","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0350","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neurobiolaging.2005.02.006","article-title":"Nimodipine selectively stimulates beta-amyloid 1\u201342 secretion by a mechanism independent of calcium influx blockage","volume":"27","author":"Facchinetti","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0355","first-page":"208","article-title":"Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type","volume":"18","author":"Bellew","year":"2004","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0360","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/gps.1851","article-title":"Nilvadipine prevents cognitive decline of patients with mild cognitive impairment","volume":"22","author":"Hanyu","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0365","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident Alzheimer disease: the Cache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0370","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0375","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1073\/pnas.0709695104","article-title":"Small molecule regulators of autophagy identified by an image-based high-throughput screen","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0380","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1021\/jm9008289","article-title":"Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors","volume":"52","author":"Mai","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0385","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1073\/pnas.0712145105","article-title":"A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy","volume":"105","author":"Lee","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0390","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2011.03.048","article-title":"Selective dihydropyiridine compounds facilitate the clearance of beta-amyloid across the blood\u2013brain barrier","volume":"659","author":"Bachmeier","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0395","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower abeta accumulation by targeting both the production and the clearance of abeta across the blood\u2013brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0400","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/mds.23308","article-title":"Tolerability of isradipine in early Parkinson's disease: a pilot dose escalation study","volume":"25","author":"Simuni","year":"2010","journal-title":"Mov. Dis."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0405","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1016\/j.bmc.2010.03.038","article-title":"Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2","volume":"18","author":"Chang","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2011.08.013_bb0410","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/mds.22801","article-title":"A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease","volume":"25","author":"Chan","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0415","doi-asserted-by":"crossref","first-page":"20733","DOI":"10.1074\/jbc.M802254200","article-title":"Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain","volume":"283","author":"Singh","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000107661","article-title":"Brain MRI and neurological deficit measurements in focal stroke: rapid throughput validated with isradipine","volume":"81","author":"Lenhard","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0425","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/exnr.1997.6611","article-title":"Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats","volume":"148","author":"Campbell","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0430","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0197-4580(99)00068-8","article-title":"L-type calcium channels in the hippocampus and cerebellum of Alzheimer's disease brain tissue","volume":"20","author":"Coon","year":"1999","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0435","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0006-8993(92)91292-M","article-title":"A correlative study of calcium channel antagonist binding and local neuropathological features in the hippocampus in Alzheimer's disease","volume":"589","author":"Ikeda","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0440","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.nbd.2009.01.008","article-title":"Isradipine antagonizes hypobaric hypoxia induced CA1 damage and memory impairment: complementary roles of L-type calcium channel and NMDA receptors","volume":"34","author":"Barhwal","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0445","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1524-6175.2006.04482.x","article-title":"Calcium channel blocker class heterogeneity: select aspects of pharmacokinetics and pharmacodynamics","volume":"7","author":"Sica","year":"2005","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0450","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-0773.2000.d01-32.x","article-title":"Bioavailability and pharmacokinetics of isradipine after oral and intravenous administration: half-life shorter than expected?","volume":"86","author":"Christensen","year":"2000","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0455","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02814999","article-title":"Neurodegenerative mechanisms in Alzheimer disease. A role for oxidative damage in amyloid beta protein precursor-mediated cell death","volume":"29","author":"Sopher","year":"1996","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0460","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0169-328X(94)90092-2","article-title":"Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein","volume":"26","author":"Sopher","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0465","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1242\/dmm.006841","article-title":"A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug","volume":"4","author":"Copenhaver","year":"2011","journal-title":"Dis. Mod. Mech."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0470","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0475","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.08.013_bb0480","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/mol.108.049981","article-title":"Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms","volume":"75","author":"Sinnegger-Brauns","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0485","first-page":"50","article-title":"State- and isoform-dependent interaction of isradipine with the alpha1C L-type calcium channel","volume":"440","author":"Lacinova","year":"2000","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0490","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.0813355106","article-title":"Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity","volume":"106","author":"Diaz","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0495","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2990.2010.01062.x","article-title":"Review: autophagy and neurodegeneration: survival at a cost?","volume":"36","author":"Cherra","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0500","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1083\/jcb.201002108","article-title":"Regulation of the autophagy protein LC3 by phosphorylation","volume":"190","author":"Cherra","year":"2010","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0505","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00424-010-0800-x","article-title":"Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels","volume":"460","author":"Striessnig","year":"2010","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0510","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/j.1552-4604.1988.tb03098.x","article-title":"The pharmacokinetics of oral isradipine in normal volunteers","volume":"28","author":"Clifton","year":"1988","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0515","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0006-8993(93)90505-H","article-title":"Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases","volume":"611","author":"Sen","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0520","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchromb.2008.11.021","article-title":"Quantification of isradipine in human plasma using LC\u2013MS\/MS for pharmacokinetic and bioequivalence study","volume":"877","author":"Park","year":"2009","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0525","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0306-3623(94)00196-T","article-title":"Peculiar effects of isradipine and darodipine on the rat brain dopaminergic system","volume":"26","author":"Gaggi","year":"1995","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.08.013_bb0530","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3109\/00498250903254340","article-title":"Cross-species comparisons of the pharmacokinetics of ibudilast","volume":"39","author":"Sanftner","year":"2009","journal-title":"Xenobiotica"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T07:42:14Z","timestamp":1712821334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443911001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":106,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0925443911001955"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2011.08.013","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}